A cDNA microarray analysis indicated that Semaphorin3B ( Sema3B ), a gene whose product is involved in axon guidance and axonal repulsion, is inducible by p53. Introduction of exogenous p53 into a glioblastoma cell line lacking wild -type p53 ( U373MG ) dramatically induced expression of Sema3B mRNA. An electrophoretic mobility shift assay and a reporter assay confirmed that a potential p53 binding site present in the promoter region had p53 -dependent transcriptional activity. Expression of endogenous Sema3B was induced in response to genotoxic stresses caused by adriamycin treatment or UV irradiation in a p53 -dependent manner. Ectopic expression of Sema3B in p53 -defective cells reduced the number of colonies in colony formation assays. These results suggest that Sema3B might play some role in regulating cell growth as a mediator of p53 tumor -suppressor activity.
Introduction
The tumor -suppressing activity of p53 protein involves elimination of cells that might otherwise become malignant as a result of severe DNA damage or critical cellular stress, through induction of cell cycle arrest and apoptosis [1] [2] [3] . The p53 protein initiates these processes by binding to a specific DNA sequence ( p53 binding site, p53BS ) present in target genes, inducing transcription of molecules that carry out the required antitumorigenic functions [ 4 ] .
We and others have demonstrated that p53 takes part in many physiological roles by transactivating dozens of target genes such as p53AIP1 [ 5 ] in p53 -mediated apoptosis, p21 / Waf1 [ 6 ] in p53 -mediated cell cycle arrest, and p53R2 [7] in repair of damaged DNA. In view of the fact that more than 100 potential p53BS are likely to be present in the human genome [ 8 ] , we assume that many p53 target genes have not yet been identified. To fully understand the entire spectrum of p53 functions including its tumor -suppressive activity, it will be essential to identify all the genes that are targets of this transcription factor. We recently reported several novel p53 target genes using a yeast enhancer trap system [ 9 -12 ] or a differential display method [ 5,7,13 -15 ] . To expand the collection of p53 targets further, we have been applying a third approach that exploits cDNA microarray technology.
In neurons, both genetic and epigenetic factors are involved in physiologic and pathophysiologic states [ 16 ] . The semaphorin family of proteins is a major agent for axonal guidance, and the axon -repulsive effects of semaphorins have been documented in vitro and in vivo [ 17 ] . All semaphorins share a conserved, 500 -amino -acid ''Sema'' domain at their amino terminals, and possess variable regions at their carboxyl ends. More than 20 semaphorins have been identified so far ( Semaphorin Nomenclature Committee, 1999 ) and are classified into eight groups on the basis of domain organization within the primary structure and the species of origin [ 18 ] . Vertebrate semaphorins are categorized into five groups, classes 3 through 7; classes 4, 5, and 6 possess transmembrane segments and class 7 is characterized by a GPI anchor motif. The Semaphorin3B ( Sema3B ) gene encodes a member of class 3, a group of secreted proteins that repulse axonal extension [ 19 ] . In the spinal cord, Sema3B is expressed in the floor plate of the midline and does not repel commissural axons that have not yet crossed the floor plate. However, once the commissural axons cross the floor plate, Sema3B inhibits their extension. Targeted inhibition of neurophilin -2, a receptor for Sema3B, leads to defects of midline guidance in mice. Thus, Sema3B appears to be a critical factor in formation of the mammalian neural network [ 19 ] . We show evidence here that Sema3B is a direct transcriptional target of p53, and that it might be involved in p53 -dependent suppression of cell growth.
Materials and Methods

Cell Lines
Human cancer cell lines U373MG ( glioblastoma ), H1299 ( lung carcinoma ), and MCF7 ( breast cancer ) were purNeoplasia . Vol. 4, No. 1, 2002, pp. 82 -87 www.nature.com/neo chased from the American Type Culture Collection ( ATCC, Manassas, VA ). T98G ( glioblastoma ) was obtained from the Japanese Collection of Research Bioresources ( JCRB, Tokyo, Japan ). All cells were cultured under conditions recommended by their respective depositors.
Detection of Genes Induced by p53
Adenoviruses containing p53 cDNA ( Ad -p53 ) orgalactosidase cDNA ( Ad -LacZ ) under control of the human cytomegalovirus promoter were generated as described previously [ 20 ] . U373MG cells, which lack wild -type p53, were infected with Ad -p53 or Ad -LacZ at a multiplicity of infection ( MOI ) of 80. Cells were collected 0, 6, 12, 24, and 48 hours later, and total RNA was extracted with TRIzol reagent ( Life Technologies, Rockville, MD ). Poly( A ) RNA was purified from each total RNA using an mRNA purification kit ( Amersham, Piscataway, NJ ). Each poly( A ) + RNA was then amplified using Ampliscribe T7 Transcription Kits ( Epicentre Technologies, Madison, WI ). Genes induced by exogenous p53 were identified by hybridizing the RNA to a cDNA microarray. Preparation of probes, hybridization procedures, and scanning were performed as described previously [ 21 ] . The fluorescent intensities of Cy5 ( Ad -p53 ) and Cy3 ( Ad -LacZ ) for each target spot were adjusted so that the mean Cy5 / Cy3 ratio of 52 housekeeping genes for each slide became equal. One induced gene, Sema3B, was selected from the microarray for further investigation.
Northern Blotting
One microgram of each poly( A ) + RNA was separated on 1% agarose gels containing 1Â 4 -morpholinepropanesulfonic acid and 2% formaldehyde, and transferred onto nylon membranes. The membranes were hybridized with random -primed, 32 P -labeled Sema3B or actin cDNA, washed with 0.1Â SSC, 0.1% SDS at 658C, and exposed for autoradiography at À 808C.
Electrophoretic Mobility Shift Assay ( EMSA )
The EMSA was performed as described previously [ 7 ] using oligonucleotides corresponding to a putative p53 binding sequence present in the promoter of Sema3B . A clone containing a C -to -T substitution at the fourth nucleotide in the p53BS was generated using a QuickChange SiteDirected Mutagenesis Kit ( Stratagene, La Jolla, CA ). Luciferase assays were performed as described previously [ 15 ] .
Colony Formation Assay
The entire coding sequence of Sema3B cDNA, with or without a FLAG tag at the 3 0 -end, was amplified by PCR using KOD -plus -PCR Polymerase ( Toyobo, Osaka, Japan ) and inserted into pcDNA3.1( + ) vector ( Invitrogen, Carlsbad, CA ). As a control, the entire coding sequence of Sema3B cDNA was inserted into pcDNA3.1( À ) vector ( Invitrogen . The transfected cells were cultured in G418 -containing culture media ( 0.6 g / ml for U373 and 0.8 g/ml for T98G and H1299 ) and stained with crystal violet 10 to 21 days later.
DNA -Damaging Treatments
MCF7 ( p53 + / + ) and H1299 ( p53 À / À ) cells were UVirradiated at different dosages ( J / m 2 ) using a UV crosslinker ( Stratagene ), or treated with adriamycin ( doxorubicin; Kyowa Hakko Kogyo, Tokyo, Japan ) at different dosages. Total RNA was isolated from the cells at selected times after treatment and expression of Sema3B was examined by Northern blotting.
Results
To identify additional p53 targets, we applied a cDNA microarray to screen for p53 -inducible transcripts [ 21 ] . We confirmed that this approach could detect the elevated expressions of several well -known p53 target genes ( Table 1 ) . Among dozens of genes that were transactivated in a time -dependent manner after intro- duction of exogeneous p53 to a p53 -deficient cell line, we confirmed significant induction of Sema3B ( GenBank NM004636 ) by a Northern blot analysis that identified its major 3.4 -kb transcript ( Figure 1A ). To investigate whether Sema3B was a direct target of p53, we searched for one or more p53 binding sequences ( p53BS ) within the gene and found a possible p53BS in its promoter region ( Figure 1B ), which revealed a 90% match to the consensus p53 binding sequence [ 4 ] with a spacer of two nucleotides ( Figure 1C ). To verify whether p53 was able to bind to oligonucleotides corresponding to this candidate p53BS, we performed EMSA ( Figure 2A ) using nuclear extracts purified from H1299 ( p53 -null ) cells infected with Ad -p53. A shifted band was observed after addition of the nuclear extract containing wild -type p53, and was supershifted when anti -p53 antibody ( Pab421 ) was added. This supershifted band was supersupershifted when another anti -p53 antibody ( Pab1801 ) was added. Unlabeled self -oligonucleotides ( Self ), but not nonspecific oligonucleotides ( TL ), inhibited the binding, indicating that p53 protein could in fact bind to this p53BS in vitro.
To clarify the p53 -dependent, transcription -enhancing activity of this p53 binding sequence, we performed a reporter assay with a luciferase gene that was fused to one ( p53BSÂ1 ) or two copies ( p53BSÂ2 ) of the p53BS inserted upstream of the SV40 promoter in a pGL3 promoter vector. These constructs were cotransfected with a wild -type p53 (wt-p53 ) expression plasmid that strongly enhanced luciferase activity. No enhancement was seen when the reporter plasmid was cotransfected with mutant p53 (mt-p53 [ 175 ] or mt -p53 [ 277 ]; Figure 2B ). We also constructed a luciferase vector containing an 880 -bp DNA fragment corresponding to the promoter region of the Sema3B gene ( Sema -pro880 -wt ) including the p53BS or the same DNA fragment with a DNA substitution within the p53BS ( Semapro880 -mt ). Luciferase activity of Sema -pro880 -wt, but not Sema -pro880 -mt, was enhanced by cotransfection of the plasmid designed to express wt -p53. This enhancement was not observed after cotransfection with plasmids designed to express mt -p53. The reporter gene assay, combined with the result of EMSA, clearly indicated that Sema3B is a bonafide target of wild -type p53.
We then examined transcriptional activation of Sema3B by endogenous p53 in response to cellular stresses causing DNA damage ( UV irradiation and adriamycin treatment ), using MCF7 ( p53 + / + ) and H1299 ( p53 À / À ) cells. As shown in Figure 3 , expression of Sema3B mRNA increased remarkably in MCF7 cells after exposure to either genotoxic stress, in a time -dependent manner. However, expression was unchanged in H1299 cells ( data not shown ). We noted that induction of p21 WAF1 in response to these treatments reached a maximum 12 and 24 hours after treatment, whereas expression of Sema3B mRNA increased up to 72 hours after the exposure. We had previously observed the same induction pattern of p53AIP1 mRNA after these exposures; this similarity implies that modification of p53 protein is required for induction of Sema3B. We performed colony formation assays to investigate the effect of Sema3B on cell growth, using expression vectors ( sense -Sema3B -FLAG or sense -Sema3B ) designed to express Sema3B protein with or without a FLAG tag at the C -terminal. As a negative control, we also prepared an expression vector in which the entire coding region of Sema3B was inserted in the antisense direction ( antisense -Sema3B ). Each of these vectors was transfected into T98G ( glioblastoma ), U373MG ( glioblastoma ), or H1299 ( lung cancer ) cells, all of which lack wild -type p53. Expression of Sema3B protein after transfection with senseSema3B -FLAG vector was confirmed by immunoblotting, using mouse anti -FLAG monoclonal antibody ( Kodak; data not shown ). After 2 weeks of incubation in geneticincontaining media, ectopic expression of Sema3B had reduced the numbers of colonies in all three cell lines ( Figure 4 ; data for U373MG not shown ). Similar results were obtained when we used sense -Sema3B -FLAG expression vector ( data not shown ), suggesting that Sema3B might play a role in either apoptosis or cell cycle arrest.
Discussion
In addition to the specific functions of semaphorins in axon guidance and axonal repulsion, emerging evidence indicates their involvement in neuronal apoptosis [ 22 ] . Semaphorin3A ( Sema3A ), a member of the same class as Sema3B, induces neuronal apoptosis by binding to its receptor, neurophilin -1 ( NRP1 ), which is known as a receptor for Sema3B [ 23, 24 ] . On the other hand, VEGF165 ( vascular endothelial growth factor ) can block Sema3A -NRP1 signaling for neuronal apoptosis by directly competing with Sema3A for binding to NRP1 [ 23, 24 ] . Therefore, the balance between Sema3A and VEGF165 might determine a cell's fate, survival, or apoptosis. We speculate that Sema3B is also involved in regulating apoptosis via binding to NRP1, by cooperating with Sema3A or competing with VEGF165.
Several groups have reported a possible role of p53 in neuronal apoptosis; for one thing, expression of p53 mRNA precedes neuronal apoptosis in neurons of injured brain and spinal cord [ 25 ] . Second, neuronal cells from p53 À / À knockout mice are resistant to apoptosis induced by neuronal injury, both in vitro and in vivo [ 26 ] . As a third line of evidence, experimental overexpression of p53 in neuronal cells can induce apoptosis [ 26, 27 ] . These data indicate that p53 plays an important role in regulating neuronal apoptosis, probably through the transcriptional regulation of target gene( s ). Indeed, in our experiments, overexpression of Sema3B suppressed the growth of neuronal and nonneuronal cancer cells. Taken together, the results support a notion that Sema3B might be one of the mediators involved in p53 -dependent apoptosis for not only neuronal cells but also non -neuronal ones. The information presented here should shed light toward a fuller understanding of the physiological functions of p53. 
